Bio-View Ltd (BIOV) - Cash Flow Conversion Efficiency

Latest as of December 2022: 0.049x

Based on the latest financial reports, Bio-View Ltd (BIOV) has a cash flow conversion efficiency ratio of 0.049x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.38 Million ≈ $3.70K USD) by net assets (ILA28.28 Million ≈ $75.81K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIOV net asset quality index to measure how much of total assets are equity-financed.

Bio-View Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Bio-View Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bio-View Ltd (BIOV) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Bio-View Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-View Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Agricore CS Holdings Berhad KLSE:0309	0.138x
Shenzhen Properties & Resources Development Group Ltd SHE:200011	-0.112x
NEXTCHIP Co. Ltd KQ:092600	-0.132x
Tek Seng Holdings Bhd KLSE:7200	0.104x
Falcon Power Co Ltd TW:1516	-0.199x
Kisan Telecom Co. Ltd KQ:035460	0.124x
ReWalk Robotics Ltd NASDAQ:LFWD	-0.584x
CLEAN TEQ WATER LTD F:9NK	N/A

Annual Cash Flow Conversion Efficiency for Bio-View Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Bio-View Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Bio-View Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA22.95 Million ≈ $61.52K	ILA-3.11 Million ≈ $-8.33K	-0.135x	-2515.71%
2023-12-31	ILA27.30 Million ≈ $73.20K	ILA153.00K ≈ $410.19	0.006x	-83.63%
2022-12-31	ILA28.28 Million ≈ $75.81K	ILA968.00K ≈ $2.60K	0.034x	-71.36%
2021-12-31	ILA27.16 Million ≈ $72.82K	ILA3.25 Million ≈ $8.71K	0.120x	+273.69%
2020-12-31	ILA25.07 Million ≈ $67.21K	ILA802.00K ≈ $2.15K	0.032x	-68.02%
2019-12-31	ILA24.95 Million ≈ $66.89K	ILA2.50 Million ≈ $6.69K	0.100x	+271.76%
2018-12-31	ILA22.75 Million ≈ $60.99K	ILA-1.32 Million ≈ $-3.55K	-0.058x	-2629.85%
2017-12-31	ILA23.45 Million ≈ $62.88K	ILA54.00K ≈ $144.77	0.002x	-98.29%
2016-12-31	ILA27.61 Million ≈ $74.01K	ILA3.73 Million ≈ $9.99K	0.135x	-33.43%
2015-12-31	ILA22.99 Million ≈ $61.63K	ILA4.66 Million ≈ $12.50K	0.203x	+12.52%
2014-12-31	ILA18.18 Million ≈ $48.75K	ILA3.28 Million ≈ $8.79K	0.180x	+196.72%
2013-12-31	ILA15.65 Million ≈ $41.95K	ILA-2.92 Million ≈ $-7.82K	-0.186x	-232.37%
2012-12-31	ILA16.69 Million ≈ $44.76K	ILA2.35 Million ≈ $6.30K	0.141x	-34.69%
2011-12-31	ILA15.20 Million ≈ $40.75K	ILA3.28 Million ≈ $8.78K	0.216x	-54.61%
2010-12-31	ILA8.18 Million ≈ $21.92K	ILA3.88 Million ≈ $10.41K	0.475x	+935.47%
2009-12-31	ILA1.55 Million ≈ $4.15K	ILA71.00K ≈ $190.35	0.046x	--

About Bio-View Ltd

TA:BIOV Israel Medical Devices

Market Cap

$31.07 Million

ILA11.59 Billion ILA

Market Cap Rank

#25034 Global

#361 in Israel

Share Price

ILA89.50

Change (1 day)

-4.69%

52-Week Range

ILA11.90 - ILA131.90

All Time High

ILA5076.00